London, UK; Brentwood, TN, US; 4 January 2007 - Protherics PLC ("Protherics" or
the "Company"), the international biopharmaceutical company focused on critical
care and cancer, announces that its acquisition of MacroMed, Inc., a private US
based drug development and manufacturing company, has completed at 4.00 pm GMT
(9.00 am MST) today.
